GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Shiller PE Ratio

Livzon Pharmaceutical Group (SZSE:000513) Shiller PE Ratio : 21.22 (As of Apr. 30, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Shiller PE Ratio?

As of today (2024-04-30), Livzon Pharmaceutical Group's current share price is ¥40.10. Livzon Pharmaceutical Group's E10 for the quarter that ended in Mar. 2024 was ¥1.89. Livzon Pharmaceutical Group's Shiller PE Ratio for today is 21.22.

The historical rank and industry rank for Livzon Pharmaceutical Group's Shiller PE Ratio or its related term are showing as below:

SZSE:000513' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.68   Med: 32.87   Max: 66.98
Current: 21.41

During the past years, Livzon Pharmaceutical Group's highest Shiller PE Ratio was 66.98. The lowest was 16.68. And the median was 32.87.

SZSE:000513's Shiller PE Ratio is ranked better than
57.71% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.85 vs SZSE:000513: 21.41

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Livzon Pharmaceutical Group's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.650. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.89 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Livzon Pharmaceutical Group Shiller PE Ratio Historical Data

The historical data trend for Livzon Pharmaceutical Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Shiller PE Ratio Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.74 29.31 26.12 19.02 19.01

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.38 21.81 20.19 19.01 19.34

Competitive Comparison of Livzon Pharmaceutical Group's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Shiller PE Ratio falls into.



Livzon Pharmaceutical Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Livzon Pharmaceutical Group's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=40.10/1.89
=21.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Livzon Pharmaceutical Group's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Livzon Pharmaceutical Group's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.65/114.6694*114.6694
=0.650

Current CPI (Mar. 2024) = 114.6694.

Livzon Pharmaceutical Group Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.175 98.200 0.204
201409 0.155 98.900 0.180
201412 0.109 99.000 0.126
201503 0.218 99.900 0.250
201506 0.182 99.500 0.210
201509 0.178 100.500 0.203
201512 0.150 100.600 0.171
201603 0.269 102.200 0.302
201606 0.200 101.400 0.226
201609 0.243 102.400 0.272
201612 0.178 102.600 0.199
201703 0.296 103.200 0.329
201706 0.237 103.100 0.264
201709 4.015 104.100 4.423
201712 0.192 104.500 0.211
201803 0.369 105.300 0.402
201806 0.308 104.900 0.337
201809 0.330 106.600 0.355
201812 0.150 106.500 0.162
201903 0.420 107.700 0.447
201906 0.370 107.700 0.394
201909 0.320 109.800 0.334
201912 0.280 111.200 0.289
202003 0.430 112.300 0.439
202006 0.640 110.400 0.665
202009 0.440 111.700 0.452
202012 0.310 111.500 0.319
202103 0.550 112.662 0.560
202106 0.580 111.769 0.595
202109 0.410 112.215 0.419
202112 0.350 113.108 0.355
202203 0.590 114.335 0.592
202206 0.500 114.558 0.500
202209 0.520 115.339 0.517
202212 0.430 115.116 0.428
202303 0.620 115.116 0.618
202306 0.600 114.558 0.601
202309 0.500 115.339 0.497
202312 0.380 114.669 0.380
202403 0.650 114.669 0.650

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Livzon Pharmaceutical Group  (SZSE:000513) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Livzon Pharmaceutical Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines